Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission
Authors:
- Rachel L. LundbergRLRachel L. Lundberg
- Katherine R. MarinoKMKatherine R. Marino
- Aastha JasrotiaAJAastha Jasrotia
- Louise S. MarandaLMLouise S. Maranda
- Bruce A. BartonBBBruce A. Barton
- Laura C. AlonsoLALaura C. Alonso
- Benjamin Udoka NwosuBNBenjamin Udoka Nwosu
- 1 January 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 30 (8) , 823-830
Abstract
Background: It is unclear whether the gold standard test for the detection of partial clinical remission (PCR) in new-onset type 1 diabetes (T1D), the insulin-dose adjusted Hemoglobin AMethods: A retrospective analysis of 204 subjects of ages 2–14 years, mean age 7.9±3.2 years, (male 7.8±3.4 years, [n=98]; female 7.9±3.0 years, [n=106], p=0.816) with new-onset T1D. Anthropometric and biochemical data were collected for the first 36 months of disease. PCR was defined by both IDAAResults: There were 86 (42.2%) (age 9.1±3.0 years; male 57%) remitters by IDAAConclusions: There were no significant differences in the number of remitters, duration of PCR, or the time of peak remission defined by IDAAKeywords
This publication has 29 references indexed in Scilit:
- The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cellsDiabetologia, 2013
- Insulin‐dose‐adjusted HbA1c‐defined partial remission phase in a paediatric population—when is the honeymoon over?Diabetic Medicine, 2012
- Role of Chronic and Acute Hyperglycemia in the Development of Diabetes ComplicationsDiabetes Technology & Therapeutics, 2011
- New Definition for the Partial Remission Period in Children and Adolescents With Type 1 DiabetesDiabetes Care, 2009
- A1C Variability and the Risk of Microvascular Complications in Type 1 DiabetesDiabetes Care, 2008
- Natural History of β-Cell Function in Type 1 DiabetesDiabetes, 2005
- Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) StudyPediatric Diabetes, 2005
- Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in SwedenJournal of Internal Medicine, 2004
- β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications TrialDiabetes Care, 2003
- Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group.Archives of Disease in Childhood, 1996